Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Rangering i aksjer #28308
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Aksjekurs
$1.11
Markedsverdi
$27.17M
Endring (1 dag)
0.19%
Endring (1 år)
58.22%
Land
KR
Handel Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategori

Driftsmargin for Dong Sung Bio Pharm.Co.,Ltd. (002210)
Driftsmargin per August 2026 TTM: -11.02%
Ifølge Dong Sung Bio Pharm.Co.,Ltd. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) -11.02%. Ved slutten av 2023 hadde selskapet en driftsmargin på 0.67%.
Historikk for driftsmargin for Dong Sung Bio Pharm.Co.,Ltd. fra 2007 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) -11.02% 47.92%
2024 -7.45% -1,211.94%
2023 0.67% -130.59%
2022 -2.19% -65.13%
2021 -6.28% 50.24%
2020 -4.18% -51.95%
2019 -8.70% 341.62%
2018 -1.97% -269.83%
2017 1.16% -140.42%
2016 -2.87% -279.38%
2015 1.60% -164.00%
2014 -2.50% -4.58%
2013 -2.62% -168.05%
2012 3.85% -15.94%
2011 4.58% -204.81%
2010 -4.37% -366.46%
2009 1.64% -36.43%
2008 2.58% -5.84%
2007 2.74% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.